POLYPEPTIDE LABORATORIES A/S: Financial statements 2023
CVR: 19056201
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
POLYPEPTIDE LABORATORIES A/S (CVR 19056201) has filed annual accounts for 2023. In 2023, the company reported a net result of DKK 3,229,000 compared with DKK -3,033,000 the year before. Equity in the 2023 report amounted to DKK 65,807,000. The solvency ratio was 99.9%.
- Profit/Loss
- DKK 3,229,000
- Equity
- DKK 65,807,000
- Total Assets
- DKK 65,843,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | - | 3.2 mio. | 65.8 mio. | - |
| 2022 | - | - | -3 mio. | 62.6 mio. | - |
| 2021 | - | - | -839 t. | 65.6 mio. | - |
| 2020 | - | 0 | 1.3 mio. | 66.5 mio. | - |
| 2019 | - | 24 t. | -824 t. | 65.2 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of May 1, 2023, Juan José Gonzalez Casanova has joined the board of directors of POLYPEPTIDE LABORATORIES A/S.
As of May 1, 2023, Jan Miller has left the board of directors of POLYPEPTIDE LABORATORIES A/S.
As of May 1, 2023, Juan José Gonzalez Casanova is registered as director of POLYPEPTIDE LABORATORIES A/S.
As of May 1, 2023, Jan Miller has stepped down as director of POLYPEPTIDE LABORATORIES A/S.
POLYPEPTIDE LABORATORIES A/S has published its annual report for 2022. The net result was DKK -3,033,000.
As of January 30, 2023, Christina Ellen Del Vecchio has joined the board of directors of POLYPEPTIDE LABORATORIES A/S.
As of January 30, 2023, Raymond De Vré has left the board of directors of POLYPEPTIDE LABORATORIES A/S.
About POLYPEPTIDE LABORATORIES A/S
POLYPEPTIDE LABORATORIES A/S is a Danish company of the type Aktieselskab based in Hillerød, founded in 1996. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named A/S PSE NR. 4948. The management consists of Raoul Bernhardt. The board consists of Juan José Gonzalez Casanova (chair), Christina Ellen Del Vecchio and Raoul Bernhardt. The company is owned by PolyPeptide Laboratories Holding (PPL) AB. The company has 0 employees (2017). In 2025, the company reported a net result of DKK 2,632,000 compared with DKK 7,060,000 the year before. Equity in the 2025 report amounted to DKK 75,499,000.